Search company, investor...

Liquidia Technologies

liquidia.com

Founded Year

2004

Stage

IPO | IPO

Total Raised

$99.3M

Date of IPO

7/26/2018

Market Cap

0.43B

Stock Price

6.39

About Liquidia Technologies

Liquidia Technologies (NASDAQ: LQDA) is a late-stage clinical biopharmaceutical company that is focused on improving the performance of medicines by precisely engineering drug particles. Liquidia's proprietary PRINT technology is designed to optimize the safety, efficacy or route of administration of a wide range of therapies by engineering uniform drug particles in a wide variety of compositions, sizes and shapes.

Headquarters Location

419 Davis Drive Suite 100

Morrisville, North Carolina, 27560,

United States

919-328-4400

Missing: Liquidia Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Liquidia Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Liquidia Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Liquidia Technologies is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Liquidia Technologies Patents

Liquidia Technologies has filed 32 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/5/2017

1/26/2021

Dosage forms, Drug delivery devices, Hypertension, Routes of administration, G protein coupled receptors

Grant

Application Date

5/5/2017

Grant Date

1/26/2021

Title

Related Topics

Dosage forms, Drug delivery devices, Hypertension, Routes of administration, G protein coupled receptors

Status

Grant

Liquidia Technologies Frequently Asked Questions (FAQ)

  • When was Liquidia Technologies founded?

    Liquidia Technologies was founded in 2004.

  • Where is Liquidia Technologies's headquarters?

    Liquidia Technologies's headquarters is located at 419 Davis Drive, Morrisville.

  • What is Liquidia Technologies's latest funding round?

    Liquidia Technologies's latest funding round is IPO.

  • How much did Liquidia Technologies raise?

    Liquidia Technologies raised a total of $99.3M.

  • Who are the investors of Liquidia Technologies?

    Investors of Liquidia Technologies include New Enterprise Associates, Canaan Partners, Morningside Ventures, Bill & Melinda Gates Foundation, Firelake Capital and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.